Clinical Trial Update: Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures [Phase 2]

View source ↗

Summary

Phase 2 trial update for Seletracetam (Ucb 44212) in adults with partial onset seizures; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy Partial

Drugs mentioned

• Seletracetam (Seletracetam)

Snippet

Sponsor: UCB S.A. - Pharma Sector | Conditions: Epilepsy, Partial | Phase 2 | Status: COMPLETED | Results posted: 2024-03-29